Daniel Ciccarone, MD, MPH

Dr. Dan Ciccarone is the Justine Miner Professor of Addiction Medicine in the Department of Family and Community Medicine at UCSF. He has been principal or co-investigator on numerous NIH-sponsored public health research projects, including his current Synthetics in Combination (SYNC) study. He is a recognized international scholar on the medical, public health, and public policy dimensions of substance use, risk, and consequences. He is Associate Editor for the International Journal of Drug Policy and recently edited an IJDP special issue on the "triple wave crisis" of opioids, heroin, and fentanyl in the US. He consults for numerous private and public entities, including the Office of National Drug Control Policy (ONDCP), the US Centers for Disease Control and Prevention (CDC), and the US Food and Drug Administration (FDA).

For over 20 years, "Dr. Dan" has been actively involved in expanding the use of clinical harm reduction technologies and services, e.g., naloxone, buprenorphine, and drug checking. He has provided harm reduction-based clinical services at several SF syringe exchanges. He is currently the volunteer Medical Director of Remedy Alliance, the US's largest not-for-profit wholesale distributor of naloxone.